[1] Ng SC et al. Worldwide incidence and prevalence of IBD in the 21st century: a systematic review of population- based studies. Lancet. 2017;390:2769-78.

[2] Kontola K et al. Increasing Incidenceof IBD, with Greatest Change Among the Elderly: A Nationwide Study in Finland, 2000-2020. J Crohns Colitis. 2023;17:706-11.

[3] Sousa P et al. Management of IBD in the elderly:A review. Dig LiverDis. 2023;55:1001-9.

[4] Charpentier C et al. Natural historyof elderly-onset IBD: a population-based cohort study. Gut. 2014;63:423-32.

[5] Sturm A et al. ECCO’s Topical Review on IBD in the Elderly. J Crohns Colitis. 2017;11:263-73.

[6] Mañosa M et al. Phenotype and natural history of elderly onset IBD: a multicentre, case-control study. Aliment Pharmacol Ther. 2018;47:605-14.

[7] Mak JWY et al. Epidemiology and Natural History of Elderly-onset IBD: ResultsFrom a Territory-wide Hong Kong IBD Registry. J Crohns Colitis. 2021;15:401-8.

[8] Zamani M et Alizadeh-Tabari S. Does Elderly-Onset IBD Increase Risk of Colorectal Cancer? A Systematic Review and Meta-Analysis. J Clin Med. 2023;13:148.

[9] Nguyen GC et al. Risk of Surgery and Mortality in Elderly- onset IBD: A Population-based CohortStudy. Inflamm Bowel Dis. 2017;23:218-23.

[10] Kariyawasam VC et al. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset IBD. Inflamm Bowel Dis. 2019;25:1390-8.

[11] Lund K et al. IBD in Adults and Elderly: The Use of Selected Non-IBD Medication Examined in a Nationwide Cohort Study. Inflammatory Bowel Diseases. 2023;izad244.

[12] Anisdahl K et al. Frailty risk and treatment strategy in elderly-onset IBD. A Norwegian nationwide population- based registry study. Dig Liver Dis. 2024;S1590-8658(24) 00262-7.

[13] Aldiabat M et al. Burden of delirium on mortality and healthcare resource utilization in geriatric patients hospita- lized for IBD. Proc (Bayl Univ Med Cent). 2024;37:509-15.

[14]  Nordestgaard RLM et al. Treatment of IBD with steroid- sparing medications is age-dependent - Results from a Danish nationwide cohort study, 2000-2018. Aliment Pharmacol Ther. Published Online First: 10 June 2024.

[15] Suárez Ferrer C et al. Efficacy and safety of biological treatment for IBD in elderly patients: Results from a GETECCU cohort. Gastroenterol Hepatol. 2024;S0210-5705 (24)00155-9.

[16] Sacleux S-C et al. Post-operative complications in elderly onset IBD: a population-based study. Aliment Pharmacol Ther. 2018;47:1652-60.

[17] https://sante.gouv.fr/prevention-en-sante/preserver-sa-sante/vaccination/calendrier-vaccinal. Date de consultation 28 novembre 2024.

[18] Mariani-Kurkdjian M et al. Diagnostic bactériologique des infections gastro-intestinales. Bactériologie Médicale. 2016;3:149-161.